Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3

(2014) A. K. Moesta et al.   JOURNAL OF IMMUNOLOGY

Cutting Edge: Viral Infection Breaks NK Cell Tolerance to "Missing Self"

(2014) J. C. Sun et al.   JOURNAL OF IMMUNOLOGY

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

(2010) H. E. Kohrt et al.   BLOOD

Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers

(2010) Lei Wu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Genotypes of NK Cell KIR Receptors, Their Ligands, and Fc  Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

(2010) D. C. Delgado et al.   CANCER RESEARCH

Neuroblastoma: Therapeutic strategies for a clinical enigma

(2010) Shakeel Modak et al.   CANCER TREATMENT REVIEWS

B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression

(2010) Andrea Borgerding et al.   EXPERIMENTAL HEMATOLOGY

Dose Finding Study for the Use of Subcutaneous Recombinant Interleukin-2 to Augment Natural Killer Cell Numbers in an Outpatient Setting for Stage 4 Neuroblastoma After Megatherapy and Autologous Stem-Cell Reinfusion

(2010) Ruth Ladenstein et al.   JOURNAL OF CLINICAL ONCOLOGY

'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection

(2010) Mark T Orr et al.   NATURE IMMUNOLOGY

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs

(2010) Vivien Béziat et al.   PLoS One

Rituximab: Mechanism of Action

(2010) George J. Weiner   SEMINARS IN HEMATOLOGY

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation

(2009) J. Yu et al.   BLOOD

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells

(2009) F. Romagne et al.   BLOOD

MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors

(2009) H. Xu et al.   CANCER RESEARCH

KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma

(2009) J. M. Venstrom et al.   CLINICAL CANCER RESEARCH

NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model

(2009) N. T. Joncker et al.   JOURNAL OF IMMUNOLOGY

Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cells

(2008) Lena-Maria Carlson et al.   CELL RESEARCH

Functions of natural killer cells

(2008) Eric Vivier et al.   NATURE IMMUNOLOGY